Critical Care

Residency Program Director:

Contact Information: 
Office: 916-734-3923
UC Davis Health
Pharmacy Department
2315 Stockton Blvd, Room 1310
Sacramento, CA 95817

Jeremiah J. Duby, PharmD, BCPS, BCCCP, FCCM
Critical Care Pharmacist, Specialist
PGY2 Critical Care Residency Program Director
UC Davis Medical Center
Associate Clinical Professor
Touro University, College of Pharmacy
UCSF, School of Pharmacy
Assistant Clinical Professor
UC Davis, College of Medicine

2021-2022 Residents:
Emily H. Hsu, Pharm.D.
Tricia Nguyen, Pharm.D.

ASHP Online Residency Directory

Program Purpose (ASHP Standard)

PGY2 pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification as BCCCP.

Program Goals and Objectives

See Required Competency Areas, Goals, and Objectives for Postgraduate Year Two (PGY2) Critical Care Pharmacy Residencies

Program Aim
The aim of the Critical Care Residency is to develop clinical pharmacists with the passion, perseverance, and skills to serve as integral member(s) of the critical care team and community.   Graduates of the Program are expected to be leaders in the field through practice, research, and teaching.

Learning Environment

The UC Davis Medical Center is an academic, tertiary care referral and Level I trauma center with ICUs dedicated to medicine, cardiology, cardiothoracic surgery, trauma, neurosurgery, burns. In addition, the UC Davis Children’s Hospital is a world-class pediatric tertiary and quaternary care “hospital within a hospital” that includes a Neonatal Intensive Care Unit (NICU), Pediatric Intensive Care Unit (PICU), and Level 1 Pediatric Trauma Center. There are a total of over 100 intensive care unit beds, one of the highest percentages of ICU beds in the United States, and a reflection of the medical center's role as a major regional referral center for complex neurology, trauma, burns, and medical cases.

The UC Davis Medical Center Pharmacy Department delivers well-established clinical programs to a range of medical and surgical services. The critical care resident is an active member of the multidisciplinary team that provides direct care to a diverse population of critically ill patients on a daily basis. The Critical Care Residency Program is individualized to meet each resident’s needs, taking into consideration previous clinical experiences and future professional goals.

Committee Involvement

The critical care resident serves as an active member of the ICU Committee and as such regularly reports on adverse drug events that occur in the ICU.  Finally, the resident provides analysis and recommendations to the ICU Committee and Pharmacy and Therapeutics Committee as requested.

Teaching & Learning Opportunities

The Critical Care Program offers many opportunities for both clinical and didactic teaching.  In the clinical setting, residents commonly serve as co-preceptors for UC San Francisco pharmacy students.  In addition, the resident will participate in staff development/education (e.g. nursing, pharmacy, medical students, house staff) and provide routine patient education. Finally, residents may elect to deliver 1 – 2 lectures for the UC San Francisco and Touro University Schools of Pharmacy.

The Scholarship of Teaching and Learning Program (STLP) is an opportunity that prepares residents to become effective clinician educators.  Residents participate in a series of interactive lectures and small group exercises that are designed to develop skills necessary to educate and train patients, caregivers, and healthcare providers.  Requirements for successful completion of the STLP program include clinical precepting (30 hours), inter-professional education (1 hour), public outreach (1 hour), small group facilitation (4 hours), didactic teaching (2 hour), and ACPE-accredited peer-to-peer presentation (1 hour).

Rotation Opportunities:

Required Block Experiences (4 weeks each)

Elective Block Experiences (4 weeks each)

  • Surgical Intensive Care Unit I (SICU I)
  • Medical Intensive Care Unit I (MICU I)
  • Burns Surgery Service
  • Neurocritical Care Service
  • Surgical Intensive Care Unit II (SICU II)
  • Medical Intensive Care Unit II (MICU II)
  • Pediatric Intensive Care Unit (PICU)
  • Cardiac Critical Care (CTICU, CCU)
  • Infectious Diseases (ID)
  • Emergency Medicine
  • Acute Pain
  • Parenteral Nutrition
  • Focused Research*
  • Toxicology

Longitudinal Rotations (52 weeks, required)

  • Research and Scholarship
  • Practice Management

*2-week rotation


Operations staffing—beyond basic training for clinical support—is not required, but it is encouraged to provide a balanced perspective and practical proficiency in patient care.  Completion of competencies assigned to inpatient clinical pharmacists is expected, including BLS and ACLS.

The service requirement is clinical and operational support for an ICU service (e.g. MICU, SICU, NCC) every 3rd weekend and 1 major holiday.  Additionally, residents may occasionally be called upon to provide clinical staff coverage for the clinical service that that they are currently serving on rotation as well a staffing some evenings to support inpatient clinical services.

Research and Projects
Research is an integral element of providing and improving patient care at UCDMC.  Challenges and questions are the natural product of endeavoring to understand and practice beyond the bounds of current evidence.  The practical purpose is to apply discoveries from the patient to the patient.  The principal motivation is clinical practice improvement through guideline development and implementation—at the institutional level—and through publication and presentation—at the regional and national level.  The driving ambition is for practical, sustainable solutions to patient problems.

Examples of our work can be found at the following link.

Appointment period: July 1, 2020 to June 30, 2021

Number of positions: 2

Stipend: $59,500 per year (paid monthly)

Fringe Benefits: 
Health, Dental and Vision insurance for resident and dependents, 21 days of Paid Time Off (PTO), 6 days Extended Sick Leave, and 4 days for Professional Development.  Travel funds (~$2500) are included in the base salary. There is a stipend for scrubs.

Use of sick leave is subject to approval by the RPD consistent with Medical House Staff Policies and Procedures.

Requirements for Successful Completion of the Residency

  • California licensure obtained per residency policy
  • Successful completion of all required learning experiences
    • No outstanding “Needs Improvement” on any required rotation goals or objectives
    • Minimum of 80% of objectives marked as “Achieved” by the end of the residency year
    • 100% of Patient Care Competency Area R1
  • A minimum of 12 months training inclusive of standard vacation, professional and sick leave
  • Completed Duty Hours log
  • Completion of the Appendix to Required Competency Areas, Goals, And Objectives For Postgraduate Year Two (Pgy2) Critical Care Pharmacy Residencies
  • Pharmacy PGY2 Critical Care competency presentation
  • Research Project:
    • Complete abstract, poster, manuscript
    • IRB approval
    • IRB Closeout (n/a if data collection is ongoing at the time of residency completion)
  • Presentation of research project at UC Collaborative
  • Completed institutional protocol, guideline, or monograph
  • Completed end-of-year self-assessment
  • Resident closeout completed in PharmAcademic, confirming all resident tasks are completed

Program Highlights: Critical Care Team

December 2018

  • Board Certified Critical Care Pharmacist (BCCCP). Board of Pharmacy Specialties-American Pharmacist Association.
    • awardees: Grace Benanti, Erin Louie, James Catlin, Chris Adams
  • Benanti GE, Brown ART, Shigle TL, Tarrand JJ, Bhatti MM, McDaneld PM, Shelburne SA, Aitken SL. Carbapenem versus Cefepime or Piperacillin-Tazobactam for the Empiric Treatment of Extended Spectrum β-lactamase Producing Escherichia coli Bacteremia in Patients with Hematologic Malignancy. Antimicrob Agents Chemother. 2018 Dec 3.

November 2018

  • Presidential Citation Award. Society of Critical Care Medicine (SCCM)
    • awardee: Jeremiah Duby

October 2018

  • Rocking Residency Research
    • National Pharmacy Preceptors Conference. Dallas, Tx.  October 13, 2018.
    • speakers: Patti Poole, Jeremiah Duby
  • Effect of Focused Benzodiazepine Use on Hospital Length of Stay in Severe Alcohol Withdrawal Syndrome. Clinical Toxicology.  (pending press)
    • authors: Jin Lee, Jeremiah Duby

September 2018

  • Multimodal Analgesia Decreases Opioid Use in Critically Ill Trauma Patients
    • Poster presentation at Annual Meeting of American Surgeons for The American Association for the Surgery of Trauma
    • authors: Kasey L. Hamrick PharmD, Carl A. Beyer, Jin A. Lee, Joseph M. Galante, Christine S. Cocanour, Jeremiah J. Duby
  • Hired: Robyn Stoianovici. Critical care triage position.
    • Robyn completed her PGY-2 critical care residency at The University of Vermont Medical Center (2017)

August 2018

  • New PGY-2 Critical Care Resident: Sierra Young.
  • Board Certified Critical Care Pharmacist (BCCCP). Board of Pharmacy Specialties-American Pharmacist Association.
    • awardee: Jin Lee

July 2018:

  • Kasey Hamrick successfully completes PGY-2 Critical Care residency.

June 2018

  • Invited Clinical Pharmacist (ICP) Program. Pharmacy Committee of the Neurocritical Care Society.
    • invited faculty: Gretchen Brophy
    • awardees: Kendra Schomer, Lara Zimmermann
  • Multimodal Analgesia Decreases Opioid Use in Critically Ill Trauma Patients. Presentation at University of California Collaborative Leadership Forum
    • Speaker: Kasey Hamrick
  • Fellow of the American College of Critical Care Medicine (FCCM)
    • inductee: Jeremiah Duby

May 2018

  • 2018 UCSF School of Pharmacy Long Teaching Award. University of California – San Francisco. School of Pharmacy.  May 4, 2018.
    • awardee: Jeremiah Duby
  • Glycemic Control in Critically Ill Surgery Patients.
    • In: Surgical Critical: A Clinically Oriented Practical Approach. Springer International Publishing.  Gewrebestrasse, Switzerland.    
    • author: Brian Beldowicz, Jeremiah Duby, Daniel Pigneri, Christine S. Cocanour

April 2018

  • Baby Girl Louie.
    • inductee (mother): Erin Louie

March 2018

  • Bivalirudin Dosing Requirements in Adult Patients on Extracorporeal Life Support With or Without Continuous Renal Replacement Therapy.
    • ASAIO J. 2018 Mar 13.
    • authors: Erin Louie, William Dager
  • Incomplete dabigatran reversal with idarucizumab. Clinical Toxicology 2018 (56:3):216-218.
    • authors: Aaron P. Steele, Jin A. Lee, William E. Dager

February 2018

  • Managing Critical Burns: Pharmacotherapy and Withdrawal. Society of Critical Care Medicine.  47th Critical Care Congress. San Antonio, TX.  February 27, 2018.
    • speaker: Jeremiah Duby
  • Snapshot Theater: Infectious Disease. Society of Critical Care Medicine.  47th Critical Care Congress. San Antonio, TX.  February 26, 2018.
    • moderator: Jeremiah
  • Snapshot Theater Presentation. Effect of Fluid De-Resuscitation On Duration of Mechanical Ventilation in Septic Shock Patients. Society of Critical Care Medicine. 47th Critical Care Congress. San Antonio, TX.  February 26, 2018.
    • authors: Brittany Newton, Rachelle Firestone

January 2018

  • Catlin JR, Adams CB, Louie DJ, Wilson MD, Louie EN. Aggressive Versus Conservative Initial Diuretic Dosing in the Emergency Department for Acute Decompensated Heart Failure. Ann Pharmacother. 2018 Jan;52(1):26-31.o
    • authors: James Catlin, Chris Adams, Erin Louie
  • Bouajram RH, Sebat CM, Love D, Louie EL, Wilson MD, Duby JJ. Comparison of Self-Reported and Behavioral Pain Assessment Tools in Critically Ill Patients. J Intensive Care Med. 2018; Jan 1.
    • authors: Rima Bouajram (2015 resident), Jeremiah Duby

December 2017

  • Chatley M, Kim A, Louie E, Schomer KJ. Impact of compliance with awakening and breathing components on outcomes.  American Society of Health-System Pharmacists.  Midyear Clinical Meeting.  December 2017.          

October 2017

  • Hypoactive delirium in the Critical Care Setting. In: Bourgeois JA, ed. Delirium: Prevention, Symptoms, and Treatment. 2017: 93-101.
    • authors: Kendra Schomer, Rachelle Firestone, Tricia Parker
  • Ignoffo R, Chan L, Knapp K, Chan E, Ip E, Bandy J, Besinque K, Colbert J, Duby JJ, Galanto JS, Gloudeman M, Havard P, Lackey G, Lozano E, Scott J, Stewart TL. Efficient and effective precepting of pharmacy students in acute and ambulatory care rotations: A Delphi expert panel study. Am J Health Syst Pharm. 2017 Oct 1;74(19):1570-1578.
    • author: Jeremiah Duby

September 2017

  • Hired: Jin A. Lee and Grace Benanti. Critical care triage position.
    • Grace completed her PGY-2 critical care residency at MD Anderson Cancer Center (2017).
    • Jin completed her PGY-2 critical care residency at UC Davis Medical Center (2017).

August 2017

  • Rocking Residency Research.  National Pharmacy Preceptors Conference.  Washington, DC. 
    • speakers: Jeremiah Duby, Patti Poole

July 2017

  • “Beyond Rat Poison: Review of Anticoagulation in the ICU.” American Association of Colleges of Nursing.  Sacramento Conference. "Diverse Topics in Acute & Critical Care Matter."
    • speaker: Jin Lee
  • Board Certified Critical Care Pharmacist (BCCCP). Board of Pharmacy Specialties-American Pharmacist Association.
    • awardee: Kendra Schomer

June 2017

  • Filtering out use of DOACs in Hemodialysis. Ann Pharmacother. 2017 Jun;51(6):511-513.
    • William E. Dager, Jin A. Lee
  • "Effect of focused benzodiazepine use on length of stay in severe alcohol withdrawal syndrome."
    • Speaker: Jin Lee
  • Employee of the Quarter. University of California Davis Medical Center. 06/1/2017.
    • Awardee Kendra Schomer

May 2017

  • Board Certified Critical Care Pharmacist (BCCCP). Board of Pharmacy Specialties-American Pharmacist Association.
    • awardee: Kendra Schomer

April 2017

  • Schomer KJ, Regalia RC. Clinical Pharmacology Consult Service: Evaluating the Use of High Expensive Pharmaceuticals. Vizient Connections Summit.
    • speaker: Kendra Schomer

March 2017

  • Duby JJ, Donnelley MA, Tasaka CL, Heintz BH.   Ch 22.  In: Murphy JE.  Clinical Pharmacokinetics.  6th ed.  Bethesda, MD: American Society of Health-System Pharmacists.  2017.
    • authors: Jeremiah Duby, Monica Donnelley, Chelsea Tasak (2014 resident)

February 2017

  • Duby JJ, Heintz SJ, Bajorek SA, Heintz BH, Durbin-Johnson BP, Cocanour CS. Prevalence and Course of Atrial Fibrillation in Critically Ill Trauma Patients. J Intensive Care Med. 2017; Feb;32(2):140-145.
    • author: Jeremiah Duby
  • Journal Club Webcast. Society of Critical Care Medicine.  February 17, 2017.
    • moderator: Jeremiah Duby

January 2017

  • Schomer KJ, Sebat CM, Adams JY, Duby JJ, Shahlaie K, Louie EL. Dexmedetomidine for Refractory Intracranial Hypertension. J Intensive Care Med
    • authors: Kendra Schomer, Jeremiah Duby, Erin Louie
  • Research Snapshot Theater: Surgery, Trauma, Burns. Society of Critical Care Medicine.  46th Critical Care Congress. Honolulu, HI.  January 22, 2017.
    • moderator: Jeremiah Duby

December 2016

  • Board Certified Critical Care Pharmacist (BCCCP). Board of Pharmacy Specialties-American Pharmacist Association.
    • awardees: Rachelle Firestone, Jeremiah Duby

August 2016

  • Hired: Kendra Schomer. Staff II pharmacist.
    • Jin completed her PGY-2 critical care residency at UC Davis Medical Center (2017).

July 2016

  • Resident of the Year. University of California Davis Medical Center.
    • awardee: Kendra Schomer

May 2016

  • Tasaka CL, Duby JJ, Pandya K, Wilson MD, Hardin KA. Inadequate Sedation During Therapeutic Paralysis: Use of Bispectral Index in Critically Ill Patients.  Drugs – Real World Outcomes.  2016 May; 3(2): 201-208. 
    • authors: Chelsea Tasaka (2014 resident)
  • Schomer KJ. Effect of Flumazenil on Hypoactive Delirium Secondary to Benzodiazepine Toxicity in the Intensive Care Unit. Western States Conference.
    • speaker: Kendra Schomer (2016 resident)

March 2016

  • 2016 Apple for Excellence in Teaching Award. University of California – San Francisco. School of Pharmacy.  March 25, 2016.
    • awardee: Jeremiah Duby

February 2016

  • Bouajram RH, Sebat CM, Love D, Louie EL, Wilson MD, Duby JJ.  Pain Assessment in Critically Ill Patients with Delirium: Self-reported Pain versus Behavioral Pain.  Society of Critical Care Medicine.  45th Critical Care Congress.  Orlando, FL.  Platform Presentation.  February 21, 2016.
    • Star Achievement Award for Research
    • speaker: Rima Bouajram (2015 resident)
  • Schomer KJ. Lower Respiratory Infections: HCAP, HAP, VAP. Touro University College of Pharmacy.
    • speaker: Kendra Schomer
  • Research Snapshot Theater: Endocrine. Society of Critical Care Medicine.  45th Critical Care Congress.  Orlando, FL.  Platform Presentation.  February 23, 2016.
    • moderator: Jeremiah Duby